ClinConnect ClinConnect Logo
Search / Trial NCT06947031

Efficacy and Safety of the Minimed 780G® Advanced Hybrid Closed Loop System (AHCL) in Patients With Type 1 Diabetes Undergoing Surgery

Launched by HOSPITAL UNIVERSITARIO SAN IGNACIO · Apr 21, 2025

Trial Information

Current as of July 09, 2025

Enrolling by invitation

Keywords

Type 1 Diabetes Advanced Hybrid Closed Loop System Time In Range Surgery

ClinConnect Summary

Patients using the Minimed 780G device who completed training and clinical follow-up in the Endocrinology Unit of San Ignacio University Hospital. Through the clinical follow-up established by the unit, patients must inform their physicians if they will be undergoing elective surgery or contact the medical team if they require emergency surgery during the recruitment period.

Data Collection Prior to the Surgical Procedure Once enrolled in the study, information about the surgical procedure will be collected, including the type of procedure and approximate duration. Patients will then be as...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:Patients older than 18 years AHCL (Minimed 780G) users undergoing elective and urgent surgery during the study period.
  • Exclusion Criteria:
  • Patients whose pump use was discontinued during the perioperative period. Pregnant patients. Patients without sensor data in the 2 weeks before and after surgery.

About Hospital Universitario San Ignacio

Hospital Universitario San Ignacio is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. As a prominent institution within the region, it combines state-of-the-art facilities with a commitment to patient-centered care and medical education. The hospital collaborates with multidisciplinary teams to conduct rigorous clinical studies aimed at improving treatment outcomes and enhancing the understanding of various health conditions. With a focus on ethical practices and regulatory compliance, Hospital Universitario San Ignacio strives to contribute significantly to the advancement of medical science and the well-being of the communities it serves.

Locations

Bogota, Cundinamarca, Colombia

Patients applied

0 patients applied

Trial Officials

Ana M Gómez Medina, Endocrinologyst

Principal Investigator

Hospital Universitario San Ignacio

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported